Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06011239 · ClinicalTrials.gov registry record · NA
Family Teams: A Study to Promote Team Collaboration in Family Medicine Clinics
A NA study of Psychological Well Being and Patient Care Team, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 614
- Enrollment target
- 5
- Study locations
NCT06011239: Completed NA study of Psychological Well Being and Patient Care Team, sponsored by University of Michigan.
NCT06011239 is a NA study of Psychological Well Being and Patient Care Team that has completed, run by University of Michigan. The registered enrollment target is 614 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06011239, a NA study of Psychological Well Being and Patient Care Team, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 614 participants
- Enrollment target
- 5
- Study locations
Study Summary
This project includes an intervention in five Michigan Medicine family medicine clinics which is designed to improve staff collaboration across different job roles.
Primary Outcome
The Team Development Measure is a 31-item questionnaire designed to the domains of communication, roles and goals, cohesion, and team primacy. Each question has four response options (strongly disagree, disagree, agree, strongly agree). Summary scores are transformed to a 0-100 scale to provide a score of team functioning and cohesiveness with a higher score indicating a better-functioning team. This measure has been validated in primary care settings and has strong psychometric properties.
Conditions Studied
Interventions
- BEHAVIORAL Team-building processes
Study Locations (5)
Michigan
- University of Michigan-Domino Farms - Ann Arbor
- University of Michigan- Briarwood - Ann Arbor
- Uniiversity of Michigan- Chelsea - Chelsea
- University of Michigan-Dexter - Dexter
- University of Michigan-Ypsilanti - Ypsilanti
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 614 participants |
| Start Date | 2023-09-08 |
| Est. Completion | 2025-10-20 |
| Phase | NA |
What the finished NCT06011239 record still lists
NCT06011239 is an interventional study that assigns participants to a tested intervention. The registered 614 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower).
The record links to 3 conditions, with Psychological Well Being appearing as the primary indexed condition, and to 1 intervention - of which Team-building processes is the first listed.
NCT06011239 lists 5 locations in 1 state (Michigan).
Frequently Asked Questions
What is clinical trial NCT06011239 about?
NCT06011239 is a clinical study titled "Family Teams: A Study to Promote Team Collaboration in Family Medicine Clinics". This project includes an intervention in five Michigan Medicine family medicine clinics which is designed to improve staff collaboration across different job roles.
What is the current status of trial NCT06011239?
This trial is currently completed. It is a NA study. The enrollment target is 614 participants. The study started on 2023-09-08. Estimated completion is 2025-10-20.
What conditions does trial NCT06011239 study?
This clinical trial studies the following conditions: Psychological Well Being, Patient Care Team, Occupational Burnout.
What interventions are being tested in trial NCT06011239?
The interventions under investigation include: Team-building processes (BEHAVIORAL).
Who is sponsoring clinical trial NCT06011239?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06011239 being conducted?
This trial has 5 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psychological Well Being
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06011239's enrollment target sits among peer trials
614 161st of 2000 higher than 1,840 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821857 · 614 participants · Phase 4
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
- NCT05006716 · 614 participants · Phase 1
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
- NCT06170788 · 614 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
- NCT07409272 · 614 participants · Phase 3
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI